Marko Tvrdic

working on next-gen neurotherapeutics

Co-founder

Exin Therapeutics· Winter 2025 San Francisco Bay Area

in LinkedIn 𝕏 @markotvrdic

2025Co-founder· Exin Therapeutics (YC W25)

Founder · since 2025

Company

Exin Therapeutics (YC W25)

Role

Co-Founder & COO

current

Stage

—

no public source

Raised

—

no public source

Based

San Francisco, California, United States

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Exin Therapeutics

AI drug discovery platform for neurotherapeutics

Winter 2025

Experience

Career

Exin Therapeutics (YC W25)
Co-founder
Co-Founder & COO · San Francisco, California, United States · 2025 – Present
2025
University of Oxford
DPhil student in Neuroscience · 2022 – 2025
2022
University of Oxford
DPhil - 2nd rotation project · 2023
2023
University of Oxford
DPhil - 1st rotation project · 2023
2023
University of Oxford
MSc Student · 2021 – 2022
2021
Creator Fund
Associate student investment partner · London Area, United Kingdom · 2024
2024
Creator Fund
Venture fellow · London Area, United Kingdom · 2023 – 2024
2023
The University of Edinburgh
Undergraduate Researcher · Edinburgh, Scotland, United Kingdom · 2021
2021
University of Split
Neuroscientist · Split, Croatia · 2019
2019
MedILS
Molecular Biologist · Split, Croatia · 2018
2018

Bio

Cofounder & COO @ Exin Therapeutics. Worked across analysis levels in bio – from molecules to complex behavior. Previously, I worked on retinal and circadian rhythm disorders, neurodevelopment, and systems and comp neuro, with a small stint in venture. Oxford MSc + PhD (on leave to build Exin).